Anixa Biosciences Inc — Director's Dealing 2011

Feb 10, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2011-02-08

Reporting Person: KRUSOS DENIS A (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-08	Common Stock	P	1400000	$0.1786	Acquired	1969880	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-08	Common Stock Purchase Warrants (Right to Buy)	$0.1786	P	1400000	Acquired	2016-02-08	Common stock (1400000)	Direct

Footnotes

F1: On February 8, 2011, Mr. Krusos purchased 1,400,000 shares of Common Stock, par value $0.01 and 1,400,000 Warrants to purchase Common Stock for an aggregate purchase price of $250,000 from CopyTele, Inc. in a private placement.

F2: Amount of securities beneficially owned represents shares held by Mr. Krusos and excludes shares Mr. Krusos has the right to acquire upon exercise of Common Stock Purchase Warrants and upon exercise of Stock Options pursuant to CopyTele, Inc. share incentive plans.